Nafamostat
Template:Short description Template:Drugbox Nafamostat mesylate (INN), a synthetic serine protease inhibitor, is a short-acting anticoagulant,[1] and it is also used for the treatment of pancreatitis. It also has some potential antiviral and anti-cancer properties.[2] Nafamostat is a fast-acting proteolytic inhibitor and used during hemodialysis to prevent the proteolysis of fibrinogen into fibrin.[3] The mechanism of action of nafamostat is as a slow tight-binding substrate, trapping the target protein in the acyl-enzyme intermediate form, resulting in apparent observed inhibition.[4][5]
It inhibits a large number of Lys/Arg specific serine proteinases, and is also a tryptase inhibitor, which is implicated in leaking blood vessels which is symptomatic of dengue hemorrhagic fever and of end-stage dengue shock syndrome.[6] It is available in a generic form already used for the treatment of certain bleeding complications in some countries, there are risks of severe complications such as: agranulocytosis, hyperkalemia, and anaphylaxis which must be weighed in non-emergency care.[7] In some countries, it used as a treatment for pancreatitis and pancreatic cancer.Script error: No such module "Unsubst".
This drug has been identified as a potential therapy for COVID-19,[8][9] with clinical trials in Japan possibly set to begin in March 2020.[10] With evidence that nafamostat is a potent anti-viral inhibitor in lung cells, a second round of clinical trials in Korea has begun with 10 hospitals participating.[11] Multiple Phase 2/3[12][13][14] and Phase 3[15][16] clinical trials for COVID-19 in different countries are ongoing.
References
<templatestyles src="Reflist/styles.css" />
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Clinical trial number NCT04473053 for "Rapid Experimental Medicine for COVID-19" at ClinicalTrials.gov
- ↑ Clinical trial number NCT04352400 for "Efficacy of Nafamostat in Covid-19 Patients (RACONA Study)" at ClinicalTrials.gov
- ↑ Clinical trial number NCT04418128 for "Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia" at ClinicalTrials.gov
- ↑ Clinical trial number NCT04483960 for "Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial" at ClinicalTrials.gov
- ↑ Clinical trial number NCT04390594 for "Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal" at ClinicalTrials.gov
Script error: No such module "Check for unknown parameters".
Script error: No such module "Navbox".